ArticleBritish journal of cancer2026

Nuclear FGF2, androgen receptor and Wnt pathway activation define a targetable subset of antiprogestin-resistant luminal breast cancer.

Virginia Figueroa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.